MATCH Arm EAY131-N

**Semantic type:** Intellectual Product

**Definition:** The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with the PI3K-beta inhibitor GSK2636771 in patients with cancers that have PTEN mutations or deletions and are PTEN positive by immunohistochemical analysis.

**Synonyms:** - EAY131-N - N